Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Compound Lysine Hydrochloride and Zinc Gluconate Granules

Approval Number

国药准字H20093136

Company南京海鲸药业股份有限公司

Registration Date

October 25, 2023

Drug Information

Generic Name

赖氨葡锌颗粒

Brand Name

瑞尔

Dosage Form

颗粒剂

Strength

每包含盐酸赖氨酸125mg、葡萄糖酸锌35mg(相当于锌5mg)

Drug Type

化学药品

Registration Date

October 25, 2023

Company Information

Applicant Company

Company Name南京海鲸药业股份有限公司

Company Address

南京市江北新区新科二路23号

Manufacturing Company

Company Name南京海鲸药业股份有限公司

Company Address

南京市江北新区新科三路18号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy